ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433,924 | +23.3% | 79,619 | +51.8% | 0.00% | – |
| Q2 2023 | $351,986 | -90.7% | 52,457 | -87.7% | 0.00% | -100.0% |
| Q1 2023 | $3,778,921 | +34.1% | 427,964 | +16.0% | 0.00% | 0.0% |
| Q4 2022 | $2,818,000 | -68.7% | 368,900 | -43.1% | 0.00% | -66.7% |
| Q1 2022 | $9,000,000 | -44.7% | 648,479 | +11.8% | 0.00% | -40.0% |
| Q4 2021 | $16,283,000 | -17.5% | 580,274 | -0.0% | 0.01% | -16.7% |
| Q3 2021 | $19,729,000 | -9.4% | 580,500 | +8.9% | 0.01% | -14.3% |
| Q2 2021 | $21,782,000 | -36.6% | 533,082 | -37.5% | 0.01% | -36.4% |
| Q1 2021 | $34,343,000 | -23.1% | 853,032 | +12.9% | 0.01% | -31.2% |
| Q4 2020 | $44,676,000 | +55.3% | 755,542 | +27.8% | 0.02% | +33.3% |
| Q3 2020 | $28,760,000 | +72.3% | 591,408 | +71.4% | 0.01% | +71.4% |
| Q2 2020 | $16,696,000 | +80.6% | 345,116 | +3.7% | 0.01% | +40.0% |
| Q1 2020 | $9,243,000 | +7.7% | 332,671 | +16.0% | 0.01% | +25.0% |
| Q4 2019 | $8,582,000 | +9.9% | 286,858 | +13.6% | 0.00% | +33.3% |
| Q3 2019 | $7,806,000 | +0.6% | 252,602 | +57.3% | 0.00% | 0.0% |
| Q2 2019 | $7,756,000 | – | 160,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |